Skip to content

Medpace Voice

Tag: Biomarkers

Clinical Development

Chronic Kidney Disease & Its Impact on Clinical Development – Part 2

  • March 25, 2021

This post is the second of a three-part blog series. In Part 2, we take a look at the biomarkers for chronic kidney disease.

Central Laboratories

Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers

  • April 28, 2020

We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…

Central Laboratories

Belgium Central Lab Expansion

  • January 3, 2020

As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…

Clinical Development

4 Key Considerations for Designing Immuno-Oncology Trials

  • July 22, 2019

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Central Laboratories

The Current Biomarker Landscape in Immuno-Oncology

  • June 13, 2019

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

Core Imaging Laboratory

Imaging Biomarkers for Autoimmune Diseases

  • January 7, 2019

Medpace Imaging Core Lab has experience and expertise in autoimmune imaging using conventional and molecular imaging methods.

Clinical Development

Exciting CNS Breakthroughs: Where the Promise Lies

  • November 2, 2018

In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…

Bioanalytical Laboratories

Medpace to Present New Biomarker Assay Validation Methods at AAPS PharmSci 360

  • October 8, 2018

This year at AAPS PharmSci 360, scientists from Medpace’s bioanalytical laboratory will be presenting two scientific posters regarding new methods for biomarker assay validation. Stop…

Central Laboratories

New Biomarker Assay Validations from Medpace’s Central Labs

  • September 12, 2018

With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.

Central Laboratories

Biomarkers for Celiac Disease Clinical Trials

  • October 2, 2017

As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical…